+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Clinical Cardiology, Heart Diseases, Symptoms and Types · Registering as Listener

ICCHDST
📅 2 – 3 Feb 2027 📍 Beirut, Lebanon 👥 Standard / Physical Participation
Listener Registration From
$150
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Clinical Cardiology, Heart Diseases, Symptoms and Types
ModeStandard / Physical
ParticipationListener
Registration fee$150.00
Bank charges (5.8%)$8.70
Total payable $158.70

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 5 SDG 9

This track focuses on the latest research and innovations in clinical cardiology, including novel diagnostic techniques and therapeutic strategies. Participants will explore the implications of these advancements for patient care and outcomes.

This session will delve into the complexities of heart failure, examining current management protocols and emerging therapies. Discussions will include patient-centered approaches and the role of multidisciplinary teams in improving outcomes.

This track will address the pathophysiology, diagnosis, and treatment of coronary heart disease and related atherothrombotic conditions. Emphasis will be placed on recent clinical trials and their implications for practice.

This session will focus on the unique challenges faced in pediatric cardiology, including congenital heart defects and acquired heart diseases in children. Innovative treatment modalities and the importance of early intervention will be highlighted.

This track will explore the prevalence, risk factors, and unique presentations of cardiovascular diseases in women. Discussions will include gender-specific approaches to prevention, diagnosis, and treatment.

This session will provide an overview of hypertension management, including recent guidelines and therapeutic advancements. The impact of lifestyle modifications and pharmacological interventions will also be discussed.

This track will examine the intricate relationship between diabetes and cardiovascular diseases, focusing on pathophysiological mechanisms and management strategies. The session will highlight the importance of integrated care for diabetic patients.

This session will showcase cutting-edge advancements in cardiac imaging modalities and technologies. Participants will discuss how these innovations enhance diagnostic accuracy and guide treatment decisions.

This track will cover the latest surgical techniques in cardiac surgery, including minimally invasive approaches and their outcomes. The role of surgical intervention in the management of complex cardiovascular conditions will be a key focus.

This session will address the diagnosis and management of various arrhythmias, including atrial fibrillation and ventricular tachycardia. Emphasis will be placed on the latest therapeutic options and patient management strategies.

This track will explore the epidemiological transition of cardiovascular diseases across different populations. Discussions will include risk factor trends and the implications for public health policy and prevention strategies.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED